NY-PYRAMID-ANALYTICS
30.11.2022 09:01:54 CET | Business Wire | Press release
Pyramid Analytics (Pyramid), a pioneering decision intelligence platform provider, continues to consistently execute on its strategy to rapidly expand channel partnerships with complementary technology companies, independent software vendors (ISV), consulting firms, value-added resellers (VAR) and systems integrators (SI) across the United Kingdom and Ireland (UKI). The London-based software company today announced new partnerships with Datazed Associates, Data Reply, and Digital Data Consultancy.
Key Points:
- Pyramid Analytics signed deals with new partners serving the IT needs of mid-size and large enterprises across the UKI: Datazed Associates (Referral Partner); Digital Data Consultancy (Systems Integrator); and Data Reply (Consultancy, Systems Integrator).
- The channel partner programme is the backbone of Pyramid’s UKI operations, accounting for a significant segment of UK revenue.
- Pyramid Analytics is recognized for channel excellence. The company was a CRN Channel Awards 2022 finalist.
- To learn more about becoming a Pyramid partner in the UK and Ireland, contact Bill Clayton, Vice President, Global Partnerships, at bill.clayton@pyramidanalytics.com.
Meet Pyramid Analytics’ New Partners
Datazed Associates is a boutique data consultancy specialising in data governance and data quality. The company’s network of experienced professionals has a strong track record in the insurance industry, having supported general insurers, Lloyd’s market firms, brokers and reinsurers.
Data Reply is the Reply group company offering a broad range of advanced analytics and AI-powered data services. Data Reply operates across industries and business functions to achieve meaningful outcomes through effective use of data.
Digital Data Consultancy provides consulting services in the areas of data management, data science, and digital experience. The company helps clients in retail, hospitality, healthcare, banking and consumer goods to master and reimagine their data, create new value, and differentiate and profit in the digital economy.
Pyramid Analytics Delivers Value for Partners
Partnerships are critical to Pyramid’s ability to scale growth. In turn, partners get access to the Pyramid Decision Intelligence Platform, an innovative augmented analytics platform which has garnered analyst accolades for its ability to transform businesses.
Pyramid Partners benefit from a range of resources to help them effectively market, sell, and deliver the Pyramid Platform, integrated solutions, and services. These include the Pyramid Partner Portal, a one-stop shop for deal management, market education content, co-branded marketing materials, and interactive tools and resources; and the Pyramid Learning Hub for self-guided and expert-led courses, and Pyramid Partner Certification programs.
United Kingdom the World’s “Next Silicon Valley”?
Jeremy Hunt, the UK’s Chancellor of the Exchequer, outlined a number of priorities in his Autumn Statement on 17 November. These included his plan to “turn the United Kingdom into the world’s next Silicon Valley.” Pyramid Analytics has operated and flourished in the UK for nearly five years and are proud of the company’s contribution to achieving this goal. The advanced analytics platform company has added three executives and numerous business development roles in its London office in 2022.
2022 has been momentous for Pyramid Analytics in the UKI:
- Pyramid executives, customers, partners, media and technology industry analysts celebrated a $120 million Series E funding round at a special event at Tower Bridge in May.
- Tom Warren, a veteran technology professional and former professional rugby player, was appointed Managing Director for the company’s UKI operations.
- Bill Clayton joined Pyramid in the new role of Vice President, Global Partnerships. He has more than 20 years of enterprise software experience. Clayton has held positions with global technology leaders including IBM and Oracle. He lives in the UK.
- Hayley Munro was appointed Vice President of Global Customer Success. This newly created role provides unified, company-wide management of this critical function under one executive. She lives in the UK.
Decision Intelligence is the Next Big Data Analytics Innovation
The next major innovation in analytics is Artificial Intelligence (AI). Applying AI across Data Prep, Business Analytics, and Data Science is what separates Decision Intelligence from traditional business intelligence tools such as Microsoft Power BI, Qlik, and Tableau. AI lowers the skills barrier by automating the highly technical work needed to prepare and analyze data and create and share reports and dashboards.
The Pyramid Decision Intelligence Platform delivers data-driven insights for anyone to make faster, more intelligent decisions. The Pyramid Platform provides instant access to any data, enables automated governed self-service for any person, and serves any analytics need, from the simple to the sophisticated. By uniquely combining Data Prep, Business Analytics, and Data Science with AI guidance in a single environment, the Pyramid Platform reduces cost and complexity while accelerating growth and innovation. This enables a strategic, organization-wide approach to Business Intelligence and Analytics.
Quotes
Bill Clayton, Vice President of Global Partner Sales, Pyramid Analytics: “Channel partnerships are an essential cornerstone of Pyramid’s growth strategy. Our highly productive and effective work with channel partners has forged a host of mutually beneficial relationships that have driven growth for all involved across the UKI. Channel partners are at the core of Pyramid’s business model. The growth and expansion of the company is firmly embedded with our channel partners.”
About Pyramid Analytics
Pyramid is what’s next in analytics. The award-winning Pyramid Decision Intelligence Platform delivers insights for faster, optimized decisions by providing direct access to any data, enabling governed self-service for any person, and meeting any analytics need in a no-code environment. The Pyramid Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. This enables a strategic, enterprise-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Schedule a demo.
Pyramid Analytics is incorporated in Amsterdam and has regional headquarters in global innovation and business centers, including London, New York City, and Tel Aviv. Our team lives worldwide because geography should not be a barrier to talent and opportunity. Investors include H.I.G. Growth Partners, Jerusalem Venture Partners (JVP), Sequoia Capital, and Viola Growth. Learn more at Pyramid Analytics.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005245/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
